{"id":"https://openalex.org/W3081958331","doi":"https://doi.org/10.1158/1538-7445.am2020-3242","title":"Abstract 3242: CT-0508 is an anti-HER2 chimeric antigen receptor (CAR) macrophage with targeted anti-tumor activity that promotes a pro-inflammatory solid tumor microenvironment","display_name":"Abstract 3242: CT-0508 is an anti-HER2 chimeric antigen receptor (CAR) macrophage with targeted anti-tumor activity that promotes a pro-inflammatory solid tumor microenvironment","publication_year":2020,"publication_date":"2020-08-15","ids":{"openalex":"https://openalex.org/W3081958331","doi":"https://doi.org/10.1158/1538-7445.am2020-3242","mag":"3081958331"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2020-3242","doi":"https://doi.org/10.1158/1538-7445.am2020-3242","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-3242","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011966705","display_name":"Michael Klichinsky","orcid":"https://orcid.org/0000-0001-8935-163X","observed_orcids":["https://orcid.org/0000-0001-8935-163X"]},"institutions":[{"id":"https://openalex.org/I4210155370","display_name":"Carisma Therapeutics (United States)","ror":"https://ror.org/04fvpm094","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Klichinsky","raw_affiliation_strings":["1Carisma Therapeutics, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Carisma Therapeutics, Philadelphia, PA;","institution_ids":["https://openalex.org/I4210155370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083530750","display_name":"Konrad R. Gabrusiewicz","orcid":"https://orcid.org/0000-0001-7857-8062","observed_orcids":["https://orcid.org/0000-0001-7857-8062"]},"institutions":[{"id":"https://openalex.org/I4210155370","display_name":"Carisma Therapeutics (United States)","ror":"https://ror.org/04fvpm094","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Konrad Gabrusiewicz","raw_affiliation_strings":["1Carisma Therapeutics, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Carisma Therapeutics, Philadelphia, PA;","institution_ids":["https://openalex.org/I4210155370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021572116","display_name":"Nicholas R. Anderson","orcid":"https://orcid.org/0000-0001-6027-9101","observed_orcids":["https://orcid.org/0000-0001-6027-9101"]},"institutions":[{"id":"https://openalex.org/I4210155370","display_name":"Carisma Therapeutics (United States)","ror":"https://ror.org/04fvpm094","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicholas Anderson","raw_affiliation_strings":["1Carisma Therapeutics, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Carisma Therapeutics, Philadelphia, PA;","institution_ids":["https://openalex.org/I4210155370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004093976","display_name":"Maggie Schmierer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155370","display_name":"Carisma Therapeutics (United States)","ror":"https://ror.org/04fvpm094","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maggie Schmierer","raw_affiliation_strings":["1Carisma Therapeutics, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Carisma Therapeutics, Philadelphia, PA;","institution_ids":["https://openalex.org/I4210155370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084433086","display_name":"Andrew J. Best","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155370","display_name":"Carisma Therapeutics (United States)","ror":"https://ror.org/04fvpm094","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew Best","raw_affiliation_strings":["1Carisma Therapeutics, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Carisma Therapeutics, Philadelphia, PA;","institution_ids":["https://openalex.org/I4210155370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042901789","display_name":"Martha E. Zeeman","orcid":"https://orcid.org/0000-0001-6904-021X","observed_orcids":["https://orcid.org/0000-0001-6904-021X"]},"institutions":[{"id":"https://openalex.org/I4210155370","display_name":"Carisma Therapeutics (United States)","ror":"https://ror.org/04fvpm094","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Martha Zeeman","raw_affiliation_strings":["1Carisma Therapeutics, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Carisma Therapeutics, Philadelphia, PA;","institution_ids":["https://openalex.org/I4210155370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080463199","display_name":"Sotheavy Chhum","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155370","display_name":"Carisma Therapeutics (United States)","ror":"https://ror.org/04fvpm094","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sotheavy Chhum","raw_affiliation_strings":["1Carisma Therapeutics, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Carisma Therapeutics, Philadelphia, PA;","institution_ids":["https://openalex.org/I4210155370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002613462","display_name":"Yumi Ohtani","orcid":"https://orcid.org/0000-0002-3820-6640","observed_orcids":["https://orcid.org/0000-0002-3820-6640"]},"institutions":[{"id":"https://openalex.org/I4210155370","display_name":"Carisma Therapeutics (United States)","ror":"https://ror.org/04fvpm094","country_code":"US","type":"company","lineage":["https://openalex.org/I4210155370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yumi Ohtani","raw_affiliation_strings":["1Carisma Therapeutics, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Carisma Therapeutics, Philadelphia, PA;","institution_ids":["https://openalex.org/I4210155370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058378222","display_name":"Olga E. Shestova","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Olga Shestova","raw_affiliation_strings":["2University of Pennsylvania, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University of Pennsylvania, Philadelphia, PA","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024476736","display_name":"Xueqing Maggie Lu","orcid":"https://orcid.org/0000-0002-7707-1232","observed_orcids":["https://orcid.org/0000-0002-7707-1232"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xueqing Lu","raw_affiliation_strings":["2University of Pennsylvania, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University of Pennsylvania, Philadelphia, PA","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023251058","display_name":"Nicholas E. Petty","orcid":"https://orcid.org/0000-0003-0361-9426","observed_orcids":["https://orcid.org/0000-0003-0361-9426"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicholas Petty","raw_affiliation_strings":["2University of Pennsylvania, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University of Pennsylvania, Philadelphia, PA","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040131783","display_name":"Xinhe Shan","orcid":"https://orcid.org/0000-0003-4976-1735","observed_orcids":["https://orcid.org/0000-0003-4976-1735"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xinhe Shan","raw_affiliation_strings":["2University of Pennsylvania, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University of Pennsylvania, Philadelphia, PA","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044952624","display_name":"Feng Shen","orcid":"https://orcid.org/0000-0001-9634-6265","observed_orcids":["https://orcid.org/0000-0001-9634-6265"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Feng Shen","raw_affiliation_strings":["2University of Pennsylvania, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University of Pennsylvania, Philadelphia, PA","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5039491957","display_name":"Saar I. Gill","orcid":"https://orcid.org/0000-0001-7946-7778","observed_orcids":["https://orcid.org/0000-0001-7946-7778"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Saar Gill","raw_affiliation_strings":["2University of Pennsylvania, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University of Pennsylvania, Philadelphia, PA","institution_ids":["https://openalex.org/I79576946"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"80","issue":"16_Supplement","first_page":"3242","last_page":"3242"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.8550000190734863,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.8550000190734863,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.057100001722574234,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.03720000013709068,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/car-macrophages","display_name":"CAR macrophages","score":0.8309999704360962},{"id":"https://openalex.org/keywords/anti-her2","display_name":"anti-HER2","score":0.8529999852180481},{"id":"https://openalex.org/keywords/chimeric-antigen-receptor","display_name":"chimeric antigen receptor","score":0.8040000200271606},{"id":"https://openalex.org/keywords/tumor-associated-macrophages","display_name":"tumor-associated macrophages","score":0.8820000290870667},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.7710000276565552},{"id":"https://openalex.org/keywords/m1-macrophage-polarization","display_name":"M1 macrophage polarization","score":0.8569999933242798},{"id":"https://openalex.org/keywords/dendritic-cell-activation","display_name":"dendritic cell activation","score":0.8029999732971191},{"id":"https://openalex.org/keywords/antigen-presentation","display_name":"antigen presentation","score":0.7110000252723694},{"id":"https://openalex.org/keywords/cross-presentation","display_name":"cross-presentation","score":0.7649999856948853},{"id":"https://openalex.org/keywords/t-cell-recruitment","display_name":"T cell recruitment","score":0.6359999775886536},{"id":"https://openalex.org/keywords/adoptive-immunotherapy","display_name":"adoptive immunotherapy","score":0.5479999780654907}],"concepts":[{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.7157095074653625},{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.6956297159194946},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5897278785705566},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5861096978187561},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.583247184753418},{"id":"https://openalex.org/C90375314","wikidata":"https://www.wikidata.org/wiki/Q3537484","display_name":"Adoptive cell transfer","level":4,"score":0.5279171466827393},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5234236717224121},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.463407963514328},{"id":"https://openalex.org/C2779244956","wikidata":"https://www.wikidata.org/wiki/Q184204","display_name":"Macrophage","level":3,"score":0.4448685646057129},{"id":"https://openalex.org/C2779830541","wikidata":"https://www.wikidata.org/wiki/Q1622829","display_name":"Microglia","level":3,"score":0.43584150075912476},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4299792945384979},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.41426604986190796},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.35299116373062134},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.27379316091537476},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.18179115653038025},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2020-3242","doi":"https://doi.org/10.1158/1538-7445.am2020-3242","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-3242","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3011632557","https://openalex.org/W4308375538","https://openalex.org/W4220752626","https://openalex.org/W4205614777","https://openalex.org/W4226032321","https://openalex.org/W4388047987","https://openalex.org/W3130624894","https://openalex.org/W4308377076","https://openalex.org/W3171965298","https://openalex.org/W3031497967"],"abstract_inverted_index":{"Abstract":[0],"Despite":[1],"recent":[2],"advances":[3],"in":[4,29,43,129,180,229,266,295,326],"T":[5,264,293,317,356],"cell":[6,28,206,336,357],"immunotherapy":[7],"for":[8,80,247,423],"the":[9,24,30,55,71,81,92,102,153,157,215,221,243,252,332,349,416,420],"treatment":[10,82],"of":[11,61,74,83,105,107,118,236,245,254,341,415,419],"human":[12,84,120,187,191,199,216,222,258,307],"cancer,":[13],"metastatic":[14],"solid":[15,131,409],"tumors":[16],"remain":[17],"an":[18,160,394],"intractable":[19],"challenge.":[20],"Macrophages":[21],"are":[22,52],"often":[23],"most":[25,47],"abundant":[26],"immune":[27,231],"tumor":[31,37,132,311,320,345,410],"microenvironment":[32,346,411],"(TME)":[33],"where,":[34],"as":[35,289,291],"immunosuppressive":[36,178],"associated":[38],"macrophages":[39,78,272,308],"(TAMs),":[40],"they":[41],"participate":[42],"disease":[44],"progression.":[45],"Currently,":[46],"macrophage":[48,335,400],"based":[49,69],"immunotherapeutic":[50],"approaches":[51],"focused":[53],"on":[54,70,282],"depletion,":[56],"repolarization,":[57],"or":[58],"phagocytic":[59],"disinhibition":[60],"TAMs.":[62],"We":[63,97,202],"have":[64,98,152],"developed":[65],"a":[66,115,142,172,196,226,274,343,407],"new":[67],"paradigm":[68],"adoptive":[72],"transfer":[73],"genetically":[75],"engineered":[76],"CAR":[77,334],"(CAR-M)":[79],"cancer.":[85],"CAR-M":[86,108,122,139],"can":[87],"be":[88],"efficiently":[89],"produced":[90],"using":[91],"chimeric":[93,396],"adenoviral":[94],"vector":[95],"Ad5f35.":[96],"previously":[99],"shown":[100],"that":[101,114,136,149,169,208,325,405],"primary":[103,119,257],"mechanism":[104],"action":[106],"is":[109,339,393],"antigen":[110,301,360,397],"dependent":[111],"phagocytosis,":[112],"and":[113,165,190,238,263,279,286,309,347,359,430],"single":[116,205],"dose":[117],"anti-HER2":[121,138,333,395],"leads":[123],"to":[124,155,305,315,328,351],"significantly":[125],"improved":[126],"overall":[127],"survival":[128],"multiple":[130],"xenograft":[133],"models.":[134],"Given":[135],"Ad5f35-transduced":[137],"(CT-0508)":[140],"adopt":[141],"unique":[143],"pro-inflammatory":[144,173,227,275,344,408],"M1-like":[145],"phenotype,":[146,276],"we":[147,194,250],"hypothesized":[148],"CT-0508":[150,170,209,219,246,255,268,298,338,392],"may":[151],"capacity":[154],"reprogram":[156],"TME":[158,200,223,248],"toward":[159,273],"activated":[161,292],"state.":[162],"Functional":[163],"evaluation":[164],"transcriptome-wide":[166],"characterization":[167],"revealed":[168],"maintain":[171,210],"phenotype":[174,213],"despite":[175],"challenge":[176],"with":[177,186,204,256,401],"environments":[179],"vitro.":[181,267],"By":[182],"engrafting":[183],"immunodeficient":[184],"mice":[185],"hematopoietic":[188],"cells":[189,193,265,294,318],"cancer":[192],"established":[195],"novel":[197],"xenografted":[198],"model.":[201],"demonstrate":[203],"resolution":[207],"their":[211],"M1":[212],"within":[214],"TME.":[217],"Additionally,":[218],"augmented":[220],"by":[224,234],"inducing":[225],"signature":[228],"surrounding":[230],"cells,":[232,262,285],"characterized":[233],"induction":[235],"MHC-II":[237],"TNF\u03b1.":[239],"To":[240],"further":[241],"investigate":[242],"potential":[244,350],"activation,":[249],"modeled":[251],"interaction":[253],"M2":[259,271],"macrophages,":[260],"dendritic":[261,284],"repolarized":[269],"bystander":[270],"induced":[277],"activation":[278],"maturation":[280],"markers":[281],"immature":[283],"recruited":[287],"resting":[288],"well":[290],"chemotaxis":[296],"assays.":[297],"demonstrated":[299],"enhanced":[300],"presentation":[302],"when":[303],"compared":[304],"control":[306],"cross-presented":[310],"derived":[312],"intracellular":[313],"antigens":[314],"CD8":[316],"after":[319],"phagocytosis.":[321],"Our":[322],"results":[323],"show":[324],"addition":[327],"direct":[329],"anti-tumor":[330,403],"activity,":[331],"product":[337],"capable":[340],"promoting":[342],"has":[348],"induce":[352],"epitope":[353],"spreading":[354],"via":[355],"recruitment":[358],"presentation.":[361],"Citation":[362],"Format:":[363],"Michael":[364],"Klichinsky,":[365],"Konrad":[366],"Gabrusiewicz,":[367],"Nicholas":[368,384],"Anderson,":[369],"Maggie":[370],"Schmierer,":[371],"Andrew":[372],"Best,":[373],"Martha":[374],"Zeeman,":[375],"Sotheavy":[376],"Chhum,":[377],"Yumi":[378],"Ohtani,":[379],"Olga":[380],"Shestova,":[381],"Xueqing":[382],"Lu,":[383],"Petty,":[385],"Xinhe":[386],"Shan,":[387],"Feng":[388],"Shen,":[389],"Saar":[390],"Gill.":[391],"receptor":[398],"(CAR)":[399],"targeted":[402],"activity":[404],"promotes":[406],"[abstract].":[412],"In:":[413],"Proceedings":[414],"Annual":[417],"Meeting":[418],"American":[421],"Association":[422],"Cancer":[424,436],"Research":[425],"2020;":[426],"2020":[427],"Apr":[428],"27-28":[429],"Jun":[431],"22-24.":[432],"Philadelphia":[433],"(PA):":[434],"AACR;":[435],"Res":[437],"2020;80(16":[438],"Suppl):Abstract":[439],"nr":[440],"3242.":[441]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2020-09-08T00:00:00"}